Boston-based health diagnostics company PathAI has secured $60 million in Series B funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced April 17.
According to its Crunchbase profile, "PathAI’s services solve the most challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable and cost-effective long-term solutions. Their solutions make discovery scalable."
The three-year-old startup has raised two previous funding rounds, including an $11 million Series A round in 2017.
The round brings total funding raised by Boston companies in software over the past month to $563 million, an increase of $530 million from the month before. The local software industry has produced 144 funding rounds over the past year, capturing a total of $2.4 billion in venture funding.
In other local funding news, video and video conferencing company Owl Labs announced a $15 million Series B funding round on April 17, led by Spark Capital.
According to Crunchbase, "Owl Labs describes its video conferencing product, called Owl, as 'the first plug-and-play smart video camera that automatically focuses on the speakers, in order to provide an immersive telepresence experience.' It 'works seamlessly with Google Hangouts, Skype and other widely used video conferencing software,' the website adds, noting that it aims to provide a hassle-free setup that doesn't require dedicated meeting rooms."
Founded in 2014, the company has raised two previous rounds, including a $6 million Series A round in 2017.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
